Clinical scenario: Residual products of conception after medication abortion

What providers need to know about recognizing and managing incomplete abortion
FacebookLinkedInXCopy Link

The scenario:

A 26-year-old (she/her) presents to your health center four weeks after a medication abortion at eight weeks of gestation. She reports bleeding was initially heavy with blood clots, and is now lighter, but she continues to have intermittent light bleeding and mild cramping. She reports she believes she is not pregnant anymore, as pregnancy symptoms have resolved, but is not sure if things are “done.” 

A transvaginal ultrasound shows a heterogeneous collection and thickened endometrial stripe, without a persistent gestational sac or evidence of an ongoing pregnancy.

What’s the diagnosis?

This presentation is consistent with an incomplete medication abortion, sometimes referred to as residual (retained) products of conception (RPOC) per the 2024 Society of Radiologists in Ultrasound (SRU) First-Trimester Lexicon.
Incomplete abortion is defined as:

  • persistent gestational sac with or without an embryo or fetus without cardiac activity
    or
  • residual pregnancy tissue

How common is incomplete abortion? 

Incomplete abortion after medication abortion is uncommon, but it is not rare. It is also not a serious adverse event, even if it is diagnosed in the emergency room. Reported rates range between 0.3% up to 3.4 % following medication abortion, with variation based on gestational duration, or when uterine anomalies, fibroids, or intrauterine scarring are present. After a procedural abortion, incomplete abortion is less common but can still occur.

When should people be evaluated for incomplete abortion?

Prompt, but not urgent evaluation, is indicated if: 

  • Bleeding or cramping persists and is not improving with time, especially beyond four weeks
  • Patient uncertainty about complete abortion is high 

Urgent evaluation is appropriate if the patient has:

  • Heavy bleeding (e.g., soaking ≥2 pads/hour for 2 hours) 
  • Syncope
  • Signs of hemodynamic instability
  • Fever, chills, worsening pelvic pain
  • Severe or escalating symptoms that don’t match expected recovery

What is the role of ultrasound in diagnosis and management of incomplete abortion?

Transvaginal ultrasound is the primary imaging tool for evaluating suspected incomplete abortion or early pregnancy loss (EPL). Interpreting the ultrasound report correctly helps guide management. The SRU consensus document provides important framing:

  • Incomplete abortion (preferred term): intracavitary echogenic tissue with internal vascularity, or a persistent gestational sac after treatment. This is the finding that most warrants clinical attention.
  • Endometrial thickness <10 mm has a high negative predictive value for incomplete abortion. If the endometrium is thin and avascular, reassurance and expectant management are usually appropriate.

Terms to avoid in this context, per the SRU, include “embryonic tissue” or “fetal tissue” when describing intracavitary material on ultrasound, as these may carry legal implications in certain clinical and legal climates.

A note on enhanced myometrial vascularity (EMV) and arteriovenous malformations (AVM): When Doppler findings are markedly abnormal, consider AVM or EMV as an alternative diagnosis before proceeding with procedural intervention, as instrumentation in this setting can precipitate hemorrhage. Further imaging (contrast-enhanced ultrasound, MRI, or CT angiography) and interventional radiology consultation may be warranted.

Can I use serum hCG to assess for incomplete abortion?

A negative urine or serum hCG following abortion can confirm a complete abortion. In the context of suspected incomplete abortion, serum hCG can be useful but a single measurement is not sufficient to make a diagnosis. After medication abortion, hCG is expected to fall by approximately 99% within 14 days. Persistently elevated hCG raises concern for incomplete or, importantly, gestational trophoblastic disease (GTD), which must remain in the differential, especially with unusually high or rising levels. Serum hCG is most helpful when interpreted alongside ultrasound findings and clinical presentation.

What management options are appropriate for incomplete abortion?

Management of incomplete abortion should be individualized based on the patient’s clinical condition, symptoms, ultrasound findings, and preferences.  Management of incomplete abortion is the same after medication or procedural abortion and EPL. Patients may change their mind on their preferred management approach at any time until the abortion is complete. 

  • Expectant management
    Appropriate for hemodynamically stable patients with:
    • minimal symptoms, and
    • smaller amounts of intracavitary material

Counseling points: Many cases will resolve spontaneously over 2–4 weeks although there is no defined upper limit for stable patients to continue expectant management. Counsel on expected symptoms (continued spotting, mild cramping) and clear return precautions.

  • Medical management with misoprostol
    • Can be considered as an alternative to expectant management in stable patients.
    • Repeat mifepristone is not indicated.

Counseling points: Available data do not show a significant difference in complete resolution rates between expectant and medical approaches at 3–4 weeks, so patient preference and clinical context should guide the choice.

  • Procedural management (uterine aspiration)
    Indicated for:
    • hemodynamic instability 
    • heavy or refractory bleeding 
    • significant intrauterine tissue with vascular flow
    • failure of expectant or medication management
    • patients desiring definitive treatment 

What counseling points about incomplete abortion should you discuss?

Validate the patient’s uncertainty:

“It’s completely understandable to feel unsure whether everything has passed. That’s one of the most common things people ask about after a medication abortion, and checking with an ultrasound is the right call.”

Explain the findings clearly:

“While you are no longer pregnant, the ultrasound shows some tissue that may still be in your uterus. The good news is that in many cases like yours, this can resolve on its own. We’re going to follow up closely to make sure.”

Set expectations for each management path:

“If we take a watch-and-wait approach, you may have some continued spotting for another week or two. I’d like to check back in with you in [X days/weeks] with another ultrasound. Here are the symptoms that would mean you should come in sooner: heavy bleeding, soaking more than two pads per hour, fever, severe cramping, foul-smelling discharge.”

Address reproductive future concerns:

“This is something that can sometimes happen after abortion. When caught and managed early, it does not impact your ability to get pregnant in the future.”

Key Points

  • Incomplete abortion (also referred to as RPOC) is defined as a  persistent gestational sac with or without an embryo or fetus without cardiac activity or residual pregnancy tissue. The terms RPOC and “residual products of conception” are accepted synonyms. Avoid the terms “embryonic tissue” or “fetal tissue” in ultrasound reports, per SRU guidance.
  • Transvaginal ultrasound is the primary diagnostic tool. An endometrial thickness <10 mm has high negative predictive value; ≥15 mm warrants further evaluation. 
  • Serum hCG is a useful adjunct; consider gestational trophoblastic disease if levels are unusually high or rising.
  • Individualize management: expectant, medication with misoprostol, and procedural options are all appropriate depending on clinical stability, symptoms, ultrasound findings, and patient preference.
  • Patient-centered counseling—validating concern, explaining findings, and providing clear return precautions—is essential to safe and supportive care.

Clinical Resources